BRISBANE, Calif., Nov. 26, 2025 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (Nasdaq: VERA), a late clinical-stage biotechnology company focused on…
Atacicept received FDA Breakthrough Therapy Designation for the treatment of IgANORIGIN Phase 3 trial met its primary endpoint at the…
October 10, 2025 16:05 ET | Source: Vera Therapeutics BRISBANE, Calif., Oct. 10, 2025 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc.…
LUXEMBOURG, June 25, 2025 /PRNewswire/ -- The Asteroid Foundation, working in collaboration with B612 Foundation, founding sponsor of Asteroid Day,…
Certified Method Enhances Global Botanical Quality and Safety BENGALURU, India, June 19, 2025 /PRNewswire/ -- Herbalife Ltd. (NYSE: HLF), a premier health and wellness company, community…